ProfileGDS4718 / 224840_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 97% 96% 95% 97% 95% 98% 94% 95% 95% 98% 94% 91% 95% 95% 95% 94% 95% 93% 95% 97% 95% 96% 96% 95% 98% 94% 94% 89% 94% 97% 91% 93% 84% 93% 95% 96% 95% 98% 95% 93% 94% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.124197
GSM549102patient 115, normal, homogenized [OPG study]10.848797
GSM549104patient 119, normal, homogenized [OPG study]11.101697
GSM549108patient 138, normal, homogenized [OPG study]10.461796
GSM549119patient 077, normal, homogenized [OPG study]10.380395
GSM549133patient 032, cancer, homogenized [OPG study]10.785997
GSM549139patient 042, cancer, homogenized [OPG study]10.07995
GSM549099patient 107, normal, homogenized [OPG study]11.201398
GSM549109patient 139, normal, homogenized [OPG study]9.9898594
GSM549110patient 046, normal, homogenized [OPG study]10.465195
GSM549114patient 063, normal, homogenized [OPG study]10.468195
GSM549122patient 082, normal, homogenized [OPG study]11.881398
GSM549134patient 033, cancer, homogenized [OPG study]10.040394
GSM549136patient 036, cancer, homogenized [OPG study]9.4901191
GSM549140patient 044, cancer, homogenized [OPG study]10.098395
GSM549111patient 047, normal, homogenized [OPG study]10.341195
GSM549113patient 057, normal, homogenized [OPG study]10.328695
GSM549132patient 031, cancer, homogenized [OPG study]9.8832794
GSM549137patient 038, cancer, homogenized [OPG study]10.116895
GSM549142patient 047, cancer, homogenized [OPG study]9.1691593
GSM549100patient 110, normal, homogenized [OPG study]10.186795
GSM549107patient 135, normal, homogenized [OPG study]10.868797
GSM549115patient 068, normal, homogenized [OPG study]10.502295
GSM549116patient 072, normal, homogenized [OPG study]10.678796
GSM549120patient 078, normal, homogenized [OPG study]10.681296
GSM549131patient 030, cancer, homogenized [OPG study]10.36295
GSM549118patient 074, normal, homogenized [OPG study]11.851198
GSM549129patient 027, cancer, homogenized [OPG study]9.8159294
GSM549123patient 088, normal, homogenized [OPG study]10.013794
GSM549124patient 006, cancer, homogenized [OPG study]8.8305489
GSM549126patient 015, cancer, homogenized [OPG study]9.8146394
GSM549128patient 025, cancer, homogenized [OPG study]10.872597
GSM549103patient 117, normal, homogenized [OPG study]9.2608191
GSM549117patient 073, normal, homogenized [OPG study]9.8980393
GSM549138patient 041, cancer, homogenized [OPG study]8.4019584
GSM549141patient 045, cancer, homogenized [OPG study]9.8093793
GSM549130patient 028, cancer, homogenized [OPG study]10.084195
GSM549101patient 111, normal, homogenized [OPG study]10.515296
GSM549105patient 128, normal, homogenized [OPG study]10.242495
GSM549106patient 134, normal, homogenized [OPG study]11.379998
GSM549112patient 048, normal, homogenized [OPG study]10.515395
GSM549125patient 011, cancer, homogenized [OPG study]9.6474293
GSM549127patient 024, cancer, homogenized [OPG study]9.8362294
GSM549135patient 035, cancer, homogenized [OPG study]9.2540890